Tasly Pharmaceutical Group Co., Ltd

This early-stage trial tests a new treatment called P134 cells for people whose glioblastoma brain cancer has come back. The treatment uses the patient's own immune cells, modified to target two markers on the cancer cells. The study aims to find the safest dose and see if it can…

This early-phase trial tests a new oral drug, TSL2109, in people with advanced solid tumors, especially metastatic castration-resistant prostate cancer and HR+/HER2- breast cancer. The study aims to find the safest dose and check for early signs of tumor shrinkage. Participants t…

This study tests a single injection of stem cells (B2065) given within 36 hours of a stroke. About 54 adults aged 18–75 with moderate-to-severe stroke will receive either the stem cells or a placebo. Researchers will monitor safety and check if the treatment helps improve recover…

This study tests whether injecting stem cells from donated umbilical cords into the heart muscle, during bypass surgery, can help people with chronic heart failure caused by blocked arteries. About 51 adults with weak hearts (ejection fraction 40% or less) will take part. The goa…

This study tests whether Lianxiaxiaopi Granules, a traditional Chinese medicine, can reduce symptoms like fullness and early fullness after eating. About 342 adults with postprandial distress syndrome will receive either the granules or a placebo. The goal is to see if the treatm…